Hyperinsulinemic Hypoglycemia After Gastric Bypass Surgery Is Not Accompanied by Islet Hyperplasia or Increased β-Cell Turnover
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Objective The purpose of this study was to establish whether hypoglycemia after gastric bypass surgery (GBS) for morbid obesity is due to increased fractional beta-cell area or inappropriately increased insulin secretion. Research design and methods We examined pancreata obtained at partial pancreatectomy from 6 patients with post-GBS hypoglycemia and compared these with 31 pancreata from obese subjects and 16 pancreata from lean control subjects obtained at autopsy. We addressed the following questions. In patients with post-GBS hypoglycemia, is beta-cell area increased and is beta-cell formation increased or beta-cell apoptosis decreased? Results We report that in patients with post-GBS hypoglycemia, beta-cell area was not increased compared with that in obese or even lean control subjects. Consistent with this finding, there was no evidence of increased beta-cell formation (islet neogenesis and beta-cell replication) or decreased beta-cell loss in patients with post-GBS hypoglycemia. In control subjects, mean beta-cell nuclear diameter correlated with BMI (r(2) = 0.79, P Conclusions We conclude that post-GBS hypoglycemia is not due to increases in beta-cell mass or formation. Rather, postprandial hypoglycemia after GBS is due to a combination of gastric dumping and inappropriately increased insulin secretion, either as a failure to adaptively decrease insulin secretion after GBS or as an acquired phenomenon.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, it is expensive and incurs risks of long-term problems, such as post-prandial hypoglycaemia, hypovolaemic dumping syndrome and micronutrient deficiencies that restrict acceptability. 24,25”
In the citing paper
“More than 25 years ago, Wing and colleagues 24 reported improvement of HbA1c, from a higher baseline level than DiRECT, after a very low calorie diet intervention under specialist supervision, with mean weight loss at 12 months of 8•6 kg.”
From Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial (2018) · cites this paper as [24]
In the citing paper
“Because the development of hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover, nesidioblastosis has not been established as the cause of late dumping syndrome (125).”
From Dumping syndrome after esophageal, gastric or bariatric surgery: Pathophysiology, diagnosis, and management (2017) · cites this paper as [125]
Citations
Cites
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Self-citationAdult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation
Dor, Y., Brown, J., Martinez, O. I., & Melton, D. A. (2004) · Nature · doi:10.1038/nature02520 · Cited by 2,219 · cited 1×
“This concept has been challenged by lineage studies in mice suggesting that new -cells arise from existing -cells rather than from newly formed islets (24).”
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297
Thomas, P. M., Cote, G. J., Wohllk, N., Haddad, B., Mathew, P. M., Rabl, W., Aguilar-Bryan, L., Gagel, R. F., & Bryan, J. (1995) · Science · doi:10.1126/science.7716548 · Cited by 806
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.
Service, G. J., Thompson, G. B., Service, F. J., Andrews, J. C., Collazo-Clavell, M. L., & Lloyd, R. V. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043690 · Cited by 779
Bonner-Weir, S., Baxter, L. A., Schuppin, G. T., & Smith, F. E. (1993) · Diabetes · doi:10.2337/diab.42.12.1715 · Cited by 675
Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea
Yoon, K. H., Ko, S. H., Cho, J. H., Lee, J. M., Ahn, Y. B., Song, K. H., Yoo, S. J., Kang, M. I., Cha, B. Y., Lee, K. W., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020735 · Cited by 649
Rubino, F., Gagner, M., Gentileschi, P., Kini, S., Fukuyama, S., Feng, J., & Diamond, E. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133117.12646.48 · Cited by 639
Nauck, M. A., Heimesaat, M. M., Behle, K., Holst, J. J., Nauck, M. S., Ritzel, R., Hüfner, M., & Schmiegel, W. H. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8355 · Cited by 605 · cited 1×
“Against this postulate, hypoglycemia has not been observed in humans exposed to long-term GLP-1 or GLP-1 mimetic treatment (18,32), and the insulinotropic effect of GLP-1 is absent at low glucose concentrations (33).”
Steinbrook, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048029 · Cited by 592
Islet Pathology and the Pathogenesis of Type 1 and Type 2 Diabetes mellitus Revisited
Klöppel, G., Löhr, M., Habich, K., Oberholzer, M., & Heitz, P. U. (1985) · Pathology and Immunopathology Research · doi:10.1159/000156969 · Cited by 577
Gastric Bypass for Obesity: Mechanisms of Weight Loss and Diabetes Resolution
Cummings, D. E., Overduin, J., & Foster-Schubert, K. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0433 · Cited by 503
Perfetti, R. (2000) · Endocrinology · doi:10.1210/en.141.12.4600 · Cited by 442
Buteau, J., Foisy, S., Joly, E., & Prentki, M. (2003) · Diabetes · doi:10.2337/diabetes.52.1.124 · Cited by 411
Patti, M. E., McMahon, G., Mun, E. C., Bitton, A., Holst, J. J., Goldsmith, J., Hanto, D. W., Callery, M., Arky, R., Nose, V., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1933-x · Cited by 365
Borg, C. M., le Roux, C. W., Ghatei, M. A., Bloom, S. R., Patel, A. G., & Aylwin, S. J. B. (2006) · British Journal of Surgery · doi:10.1002/bjs.5227 · Cited by 318
Strader, A. D., Vahl, T. P., Jandacek, R. J., Woods, S. C., D’Alessio, D. A., & Seeley, R. J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00153.2004 · Cited by 291
Glucagon-like peptide 1(GLP-1) in biology and pathology
Meier, J. J., & Nauck, M. A. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.538 · Cited by 288 · cited 2×
“Against this postulate, hypoglycemia has not been observed in humans exposed to long-term GLP-1 or GLP-1 mimetic treatment (18,32), and the insulinotropic effect of GLP-1 is absent at low glucose concentrations (33).”
Self-citationNesidioblastoma, the islet tumor of the pancreas.
(1938) · PubMed Central · Cited by 272
Extra-insular beta cells associated with ductules are frequent in adult human pancreas
Bouwens, L., & Pipeleers, D. G. (1998) · Diabetologia · doi:10.1007/s001250050960 · Cited by 229
Dunne, M. J., Kane, C., Shepherd, R. M., Sanchez, J. A., James, R. F. L., Johnson, P. R. V., Aynsley-Green, A., Lu, S., Clement, J. P., Lindley, K. J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361005 · Cited by 221
Service, F. J., Natt, N., Thompson, G. B., Grant, C. S., van Heerden, J. A., Andrews, J. C., Lorenz, E., Terzic, A., & Lloyd, R. V. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5645 · Cited by 196
Bonner-Weir, S., Baxter, L. A., Schuppin, G. T., et al. (1993) · Diabetes · doi:10.2337/diabetes.42.12.1715 · Cited by 195
Clements, R. H., Gonzalez, Q. H., Long, C. I., Wittert, G., & Laws, H. L. (2004) · The American Surgeon · doi:10.1177/000313480407000101 · Cited by 176
Anlauf, M., Wieben, D., Perren, A., Sipos, B., Komminoth, P., Raffel, A., Kruse, M. L., Fottner, C., Knoefel, W. T., Mönig, H., et al. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000151617.14598.ae · Cited by 167
Service, F. J. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.5.1582 · Cited by 163
STUDER, H., & DERWAHL, M. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-411 · Cited by 148
Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia
Toft-Nielsen, M., Madsbad, S., & Holst, J. J. (1998) · Diabetologia · doi:10.1007/s001250051049 · Cited by 132 · cited 1×
“Alternatively, the increased insulin secretion in these patients could be due to the actions of increased GLP-1 concentrations after GBS (31).”
(1997) · PubMed · Cited by 101
β-Cell Function in Morbidly Obese Subjects During Free Living
Camastra, S., Manco, M., Mari, A., Baldi, S., Gastaldelli, A., Greco, A. V., Mingrone, G., & Ferrannini, E. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2382 · Cited by 100
Secondary hyperparathyroidism: Review of the disease and its treatment
de Francisco, Á. L. M. (2004) · Clinical Therapeutics · doi:10.1016/j.clinthera.2004.12.011 · Cited by 88
Gastric Bypass and Nesidioblastosis — Too Much of a Good Thing for Islets?
Cummings, D. E. (2005) · New England Journal of Medicine · doi:10.1056/nejme058170 · Cited by 85
Chari, S. T., Zapiach, M., Yadav, D., & Rizza, R. A. (2005) · Pancreatology · doi:10.1159/000085276 · Cited by 83
Norman, J. T., Bohman, R., Fischmann, G. P. A., Bowen, J. W., McDonough, A., Slamon, D. J., & Fine, L. G. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6768 · Cited by 80
Meier, J. J., Nauck, M. A., & Butler, P. C. (2006) · Diabetologia · doi:10.1007/s00125-005-0114-2 · Cited by 64
Self-citationGIP increases insulin receptor affinity and cellular sensitivity in adipocytes
Starich, G. H., Bar, R. S., & Mazzaferri, E. L. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.249.6.e603 · Cited by 56
Shermeta, D. W., Mendelsohn, G., & HALLER, J. A. (1980) · Annals of Surgery · doi:10.1097/00000658-198002000-00009 · Cited by 30
Histologic Findings in Persistent Hyperinsulinemic Hypoglycemia of Infancy: Australian Experience
Jack, M., Walker, R. M., Thomsett, M. J., Cotterill, A. M., & BELL, J. R. (2000) · Pediatric and Developmental Pathology · doi:10.1007/s100240010117 · Cited by 29
In search of endocrine progenitor/stem cells in the human pancreas
Hayek, A. (2004) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2004.00081.x · Cited by 9
Cited by
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Metadata
- Authors
- Meier, J. J., Butler, A. E., Galasso, R., & Butler, P. C.
- Affiliations
- University of California, Los Angeles (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2006-07-01
- Volume
- 29
- Issue
- 7
- Pages
- 1554-1559
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2110392605
- Semantic Scholar
- 2010414da50cb2c6961283fded5fb9aa1739dbb8
- Cited by
- 249
- References
- 38
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 12 · 2022: 9 · 2021: 10 · 2020: 5 · 2019: 10 · 2018: 10 · 2017: 10 · 2016: 20 · 2015: 20 · 2014: 15 · 2013: 17 · 2012: 14
- FWCI
- 17.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK59579, R01DK061539, DK 61539, R01DK059579)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gastric bypass, postprandial hypoglycemia, beta-cell mass, beta-cell hyperplasia, beta-cell turnover, islet neogenesis, beta-cell apoptosis, morbid obesity, insulin secretion, pancreas
- MeSH terms
- Insulin Secretion, Adult, Cell Nucleus, Dumping Syndrome, Female, Humans, Hyperinsulinism, Hyperplasia, Hypoglycemia, Insulin, Islets of Langerhans, Male, Middle Aged, Obesity, Morbid, Gastric Bypass, Body Mass Index, Cell Size, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.